期刊
ENDOCRINOLOGY AND METABOLISM
卷 35, 期 4, 页码 696-715出版社
KOREAN ENDOCRINE SOC
DOI: 10.3803/EnM.2020.807
关键词
Thyroid neoplasms; Classification; Diagnosis; Prognosis; Mutation; Clinical decision-making
资金
- Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and ICT [NRF-2020R1F1-A1070028]
Advances in medical sciences and evidence-based medicine have led to momentous changes in classification and management of thyroid neoplasms. Much progress has been made toward avoiding overdiagnosis and overtreatment of thyroid cancers. The new 2017 World Health Organization (WHO) classification of thyroid neoplasms updated the diagnostic criteria and molecular and genetic characteristics reflecting the biology and behavior of the tumors, and newly introduced the category of borderline malignancy or uncertain malignant potential. Some neoplasms were subclassified, renamed, or redefined as a specific entity. This review introduces changes in the fourth edition WHO classification of thyroid tumors and updates the contemporary diagnosis and classification of thyroid tumors. We also discuss several challenges with the proposal of new diagnostic entities, since they have unique histopathologic and molecular features and clinical relevance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据